These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8593260)

  • 1. Lyophilized aqueous based polymer matrices for transdermal delivery of captopril.
    Dubey BK; Katare OP; Singh R; Jain SK
    J Dermatol Sci; 1995 Nov; 10(3):191-5. PubMed ID: 8593260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation Studies of Captopril Transdermal Films Through Human Cadaver Skin.
    Nair RS; Nair S
    Curr Drug Deliv; 2015; 12(5):517-23. PubMed ID: 25675336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization.
    Kerimoğlu O; Keskin E; Dortunç B; Anah S
    Acta Pol Pharm; 2013; 70(2):291-300. PubMed ID: 23614285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of patches for transdermal delivery of losartan potassium.
    Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
    PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption.
    Gullick DR; Pugh WJ; Ingram MJ; Cox PA; Moss GP
    Drug Dev Ind Pharm; 2010 Aug; 36(8):926-32. PubMed ID: 20184419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine.
    Mittal A; Sara UV; Ali A
    Acta Pharm; 2009 Dec; 59(4):383-93. PubMed ID: 19919928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
    Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
    J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
    Aqil M; Ali A; Sultana Y; Najmi AK
    Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of a losartan transdermal system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M
    Drug Dev Ind Pharm; 2010 Apr; 36(4):385-92. PubMed ID: 20205600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation.
    Aqil M; Ali A
    Eur J Pharm Biopharm; 2002 Sep; 54(2):161-4. PubMed ID: 12191687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adhesives and permeation enhancers on the skin permeation of captopril.
    Park ES; Chang SJ; Rhee YS; Chi SC
    Drug Dev Ind Pharm; 2001 Oct; 27(9):975-80. PubMed ID: 11763476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.
    Rao PR; Diwan PV
    Drug Dev Ind Pharm; 1998 Apr; 24(4):327-36. PubMed ID: 9876592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHARMACODYNAMICAL EVALUATION OF MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING CAPTOPRIL.
    Kerımoğlu O; Şahbaz S; Şehırlı Ö; Ozdemır ZN; Çetınel Ş; Dortunç B; Şener G
    Acta Pol Pharm; 2015; 72(4):799-806. PubMed ID: 26647638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of matrix-membrane transdermal drug delivery system for atenolol.
    Gupta SP; Jain SK
    Drug Deliv; 2004; 11(5):281-6. PubMed ID: 15742552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices.
    Gupta R; Mukherjee B
    Drug Dev Ind Pharm; 2003 Jan; 29(1):1-7. PubMed ID: 12602487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate.
    Bhatt DC; Dhake AS; Khar RK; Mishra DN
    Yakugaku Zasshi; 2008 Sep; 128(9):1325-31. PubMed ID: 18758147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.
    Mukherjee B; Mahapatra S; Gupta R; Patra B; Tiwari A; Arora P
    Eur J Pharm Biopharm; 2005 Apr; 59(3):475-83. PubMed ID: 15760728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
    Kalita B; Das MK; Sarma M; Deka A
    AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.